The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2018

Filed:

Jul. 16, 2014
Applicant:

Biocure, Inc., Norcross, GA (US);

Inventors:

Dennis W. Goupil, Norcross, GA (US);

Hassan Chaouk, Atlanta, GA (US);

Troy Holland, Suwanee, GA (US);

Bruktawit T. Asfaw, Atlanta, GA (US);

Stephen D. Goodrich, Norcross, GA (US);

Lucas Latini, Norcross, GA (US);

Assignee:

BioCure, Inc., Norcross, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/765 (2005.12); A61B 17/12 (2005.12); A61L 24/00 (2005.12); A61L 24/06 (2005.12); A61L 27/34 (2005.12); A61L 27/16 (2005.12); A61L 29/04 (2005.12); A61L 31/04 (2005.12); A61L 31/10 (2005.12); A61L 27/52 (2005.12);
U.S. Cl.
CPC ...
A61B 17/12022 (2012.12); A61B 17/1219 (2012.12); A61B 17/12099 (2012.12); A61B 17/12113 (2012.12); A61B 17/12122 (2012.12); A61B 17/12186 (2012.12); A61B 17/12195 (2012.12); A61L 24/0031 (2012.12); A61L 24/06 (2012.12); A61L 27/16 (2012.12); A61L 27/34 (2012.12); A61L 27/52 (2012.12); A61L 29/041 (2012.12); A61L 31/048 (2012.12); A61L 31/10 (2012.12);
Abstract

Embolic compositions comprising macromers having a backbone comprising a polymeric backbone comprising units with a 1,2-diol or 1,3-diol structure, such as polyvinyl alcohol, and pendant chains bearing crosslinkable groups and, optionally, other modifiers. When crosslinked, the macromers form hydrogels having many properties advantageous for use as embolic agents to block and fill lumens and spaces. The embolic compositions can be used as liquid embolic agents and crosslinked in situ or as preformed embolic articles, such as microspheres.


Find Patent Forward Citations

Loading…